Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability and pharmacokinetics of AVI-7288 in healthy adult volunteers has completed, sponsored by Sarepta Therapeutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Hemorrhagic Fever

Drugs mentioned

• AVI-7288

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Marburg Hemorrhagic Fever | Phase 1 | Status: COMPLETED